rs1057519548
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PS1PM2PP5_Moderate
The NM_021072.4(HCN1):c.459G>T(p.Met153Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely pathogenic in ClinVar.
Frequency
Consequence
NM_021072.4 missense
Scores
Clinical Significance
Conservation
Publications
- developmental and epileptic encephalopathy, 24Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- generalized epilepsy with febrile seizures plusInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- generalized epilepsy with febrile seizures plus, type 10Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HCN1 | ENST00000303230.6 | c.459G>T | p.Met153Ile | missense_variant | Exon 2 of 8 | 1 | NM_021072.4 | ENSP00000307342.4 | ||
HCN1 | ENST00000673735.1 | c.459G>T | p.Met153Ile | missense_variant | Exon 2 of 9 | ENSP00000501107.1 | ||||
HCN1 | ENST00000634658.1 | c.459G>T | p.Met153Ile | missense_variant | Exon 2 of 2 | 3 | ENSP00000489134.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
The p.M153I variant (also known as c.459G>T), located in coding exon 2 of the HCN1 gene, results from a G to T substitution at nucleotide position 459. The methionine at codon 153 is replaced by isoleucine, an amino acid with highly similar properties. This variant has been determined to be the result of a de novo mutation or germline mosaicism in one family with an isolated case of epilepsy (Ambry internal data). A different variant (c.459G>C) resulting in the same amino acid substitution has also been reported to be de novo in an individual with early infantile epileptic encephalopathy (Parrini E et al. Hum. Mutat., 2017 Feb;38:216-225). In addition, this amino acid position is highly conserved in available vertebrate species. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at